General questions
Data & Methods
Results & Conclusions
100

In which journal was this article published?

Journal of Neuroinflammation

100

How many participants were in the discovery cohort?

20

100

How many SNPs were selceted for the validation cohort?

16

200

What disease is the study based on?

Multiple sclerosis

200

Which two phenotypes were the two cohorts groups selected from?

Benigne and aggressive

200

Were the results conclusive? (explain)

Yes

300

What is the aim of the study?

In the present study, we aimed to identify genes associated with MS disease course by first applying an exome sequencing approach to a discovery cohort of MS patients with benign and aggressive disease courses, followed by the validation of selected genetic variants in two independent cohorts of patients with divergent disease courses.

300

What is a discovery cohort?

A discovery cohort is a study of the population, from which you collect biomarkers

300

In which genes did they identify genetic variants?

CPXM2, and NLRP9, IGSF9B

400

What do you think the impact factor for this journal is? Argument your answer with at least 2 reasons. 

5.49

Very specific journal 

It has not been cited


400

How are validation cohorts different from discovery cohorts?


Validation cohorts are "learning machines" where the results from discovery cohorts are tested and applied to suspected populations. 

400

Where (which cells) were all the 3 genes expressions dected?

Macrophages & Microglia

500

What is the authors' future hope for the results of this study?

"Finally, aiming to provide a personalized medicine in MS, the reported polymorphisms may become disease activity biomarkers to identify MS patients with diverging disease courses."

500

What tecnique was used to determine the gene expression levels of the three genes in the study?

real time PCR

500

How did they choose the SNPs? (criterias)

odds to ratio difference

phenotype prevalence

number of SNPs- gene

variant effect

relevance to MS